Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (97)

Advertisement

Research Article Free access | 10.1172/JCI107624

Hyperglucagonemia of Renal Failure

Gordon L. Bilbrey, Gerald R. Faloona, Martin G. White, James P. Knochel, and Julio Borroto

Veterans Administration Hospital, Dallas, Texas 75216

University of Texas Southwestern Medical School, Dallas, Texas 75235

Find articles by Bilbrey, G. in: JCI | PubMed | Google Scholar

Veterans Administration Hospital, Dallas, Texas 75216

University of Texas Southwestern Medical School, Dallas, Texas 75235

Find articles by Faloona, G. in: JCI | PubMed | Google Scholar

Veterans Administration Hospital, Dallas, Texas 75216

University of Texas Southwestern Medical School, Dallas, Texas 75235

Find articles by White, M. in: JCI | PubMed | Google Scholar

Veterans Administration Hospital, Dallas, Texas 75216

University of Texas Southwestern Medical School, Dallas, Texas 75235

Find articles by Knochel, J. in: JCI | PubMed | Google Scholar

Veterans Administration Hospital, Dallas, Texas 75216

University of Texas Southwestern Medical School, Dallas, Texas 75235

Find articles by Borroto, J. in: JCI | PubMed | Google Scholar

Published March 1, 1974 - More info

Published in Volume 53, Issue 3 on March 1, 1974
J Clin Invest. 1974;53(3):841–847. https://doi.org/10.1172/JCI107624.
© 1974 The American Society for Clinical Investigation
Published March 1, 1974 - Version history
View PDF
Abstract

Elevation of plasma glucagon concentration has been observed in starvation and illnesses associated with increased catabolism such as diabetes mellitus and severe infections. Thus, we examined plasma glucose, immunoreactive insulin (IRI, microunits per milliliter) and glucagon (IRG, picograms per milliliter) responses to a beef meal (1 g/kg body wt) and intravenous glucose (1.5 g/min for 45 min) in patients with chronic renal failure (CRF).

After the beef meal (n = 6), plasma glucose did not change, IRI rose from 10.1±1.2 to 16.3±1.1 (P < 0.01), and IRG rose from a fasting value of 225±26 to 321±40 (P < 0.01) by 90 min (mean±SEM).

Intravenous infusion of glucose in CRF patients resulted in significant elevations and prolonged disappearance of plasma glucose and insulin when compared to control subjects (P < 0.01). Glucose infusion failed to suppress elevated plasma glucagon concentrations to normal levels.

6 wk of chronic hemodialysis in five patients resulted in normal plasma glucose and insulin responses to the same intravenous glucose load. In contrast, plasma glucagon concentration remained unchanged after hemodialysis and there was no correlation of plasma glucagon levels with carbohydrate intolerance.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 841
page 841
icon of scanned page 842
page 842
icon of scanned page 843
page 843
icon of scanned page 844
page 844
icon of scanned page 845
page 845
icon of scanned page 846
page 846
icon of scanned page 847
page 847
Version history
  • Version 1 (March 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (97)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts